Learning Objectives
- Describe how HIV is transmitted and dispel some of the common misconceptions about how one cannot get HIV.
- Describe the presence and possibility of transmission of HIV in households, food¬service establishments, through kissing, biting, saliva, tears, sweat and insects.
- Describe the natural history of HIV infection in adults and the progression of the disease to AIDS.
- Discuss the CDC system for classifying HIV infection and AIDS in adults and adolescents in the U.S. and identify clinical conditions under each of the three categories.
- Define “viral set-point” and indicate its use in predicting the rate of future progression of the illness.
- List various laboratory tests used as indicators of prognosis and/or stage of illness in HIV infection and weigh their advantages and disadvantages.
- List host factors, viral factors, acquired factors and clinical indicators that influence the rate of HIV -disease progression.
- Identify the three primary routes of HIV transmission and indicate the relative risk of infection.
- Discuss the three factors-infectiousness of the host, susceptibility of the recipient and the quantity and infectivity of the virus-that influence the transmission of HIV infection.
- Identify the HIV / AIDS prevention needs of women.
- Address the special challenges posed to the prevention of HIV epidemic in the African American community.
- Describe the epidemiology of HIV/AIDS among Hispanics in the U.S. and compare HIV exposure risks for U.S.-born Hispanics and Hispanics born in their countries.
- Describe the epidemiology of HIV/AIDS among America’s youth.
- Describe the standard screening test for antibody to HIV and contrast it with the rapid HIV testing.
- Discuss the various advantages and disadvantages of rapid HIV test as compared to an EIA.
- Understand the importance of measuring HIV-RNA blood levels (viral load.)
- Explain what “undetectable” level of HIV in the blood means.
- List 5 steps for the correct use of condoms.
- Make the connection between sexually transmitted diseases and HIV and explain how other STDs facilitate HIV transmission.
- Point to the new evidence of the effectiveness of STD treatment in HIV prevention.
- Point to statistics showing the effectiveness of condoms in preventing HIV and STDs.
- Discuss the study sponsored by the CDC that quantified the risk of HIV infection associated with oral transmission.
- Describe the prevalence of HIV among men who have sex with men and outline the measures to combat the spread of STDs and HIV in this population group.
- Describe the risk of HI V transmission among women who have sex with women and list 3 specific measures that should be taken to reduce their risk of contracting HIV.
- Discuss the injection drug use and the transmission of HIV and other blood-borne infections.
- Make 3 specific recommendations to drug users who continue to inject to reduce the public and individual health risks.
- Describe the extent of the problem in curbing the transmission of HIV and other blood-borne diseases in the intravenous drug-using (IDU) population.
- Enunciate the 4 basic principles underlying the comprehensive approach to working with IDUs.
- Define universal precautions and list body fluids to which universal precautions apply and those to which they do not apply.
- Discuss precautions that a healthcare worker should take for other body fluids in special settings.
- Describe general guidelines for healthcare workers in the use of protective barriers.
- Discuss why the routine use of gloves for all phlebotomies is not necessary.
- Identify general guidelines in the selection and use of gloves in healthcare settings
- Evaluate the risk healthcare workers face of getting HIV on the job.
- Evaluate the risk of patients in a dentist’s or doctor’s office of getting HIV.
- Review the effectiveness of HIV prevention programs targeted toward changing personal behaviors, sexual education, intravenous drug users, HIV -infected pregnant women, blood banks and healthcare workers.
- Recount the dramatic success of protease inhibitors in the treatment of patients infected with HIV.
- Answer specific questions of people living with HIV/AIDS, including progression to AIDS, opportunistic infections, antiretroviral drug therapy and safe sexual behavior.
Table of Contents
- Human Immunodeficiency Virus (HIV)
- HIV and Its Transmission
- How HIV Is Transmitted
- HIV in the Environment
- Households
- Businesses and Other Settings
- Kissing
- Biting
- Saliva, Tears, and Sweat
- Insects
- Epidemiology and Natural History of HIV Infection
- Introduction
- HIV Transmission
- Modes of Transmission
- Factors Facilitating Transmission
- Infectiousness of the Host
- Susceptibility of the Recipient
- Viral Properties
- Natural History and HIV Disease Progression
- Staging
- Untreated Natural History
- Primary or Acute Infection
- Established Infection
- Time Course
- Laboratory Indicators and Predictors
- Long-Term Non-Progressors
- Gender Effects
- Natural History in HAART Era
- Industrialized Countries
- References
- HIV/AIDS Among U.S. Women
- Heterosexual Contact Now Is Greatest Risk for Women
- Prevention Needs of Women
- HIV/AIDS Among African Americans
- Prevention Efforts Must Focus on High-Risk Behaviors
- Interrelated Prevention Challenges in African American Communities
- HIV/AIDS Among Hispanics in the United States
- Historical Trends in AIDS Cases Among U.S. Hispanics
- Building Better Prevention Programs for Hispanics
- HIV/AIDS Among America’s Youth
- Improving HIV Prevention for Young People
- Healthcare Workers with HIV/AIDS
- HIV Testing
- Overview for HIV Antibody Testing
- Rapid HIV Test: Questions/Answers
- General Questions
- What has been the routine test for HIV antibody testing?
- What is rapid HIV testing?
- What is the difference between a rapid HIV test and an EIA?
- What rapid HIV tests be available in the future?
- Will other rapid HIV tests be available in the future?
- Who can be tested with a rapid HIV test?
- Does the rapid HIV test cost more than the EIA?
- Can I expect to see rapid HIV testing in most clinics and doctors’ offices soon?
- Are rapid HIV tests more accurate or less accurate than EIAs?
- What is predictive value?
- Does a negative rapid HIV test result mean that a person has nothing to worry about?
- What is “reactive” HIV test result?
- After a reactive rapid HIV test result, how long does a person have to wait for the confirmatory test result?
- Questions-Technical, Counseling, and Implementation
- What is the cost of rapid HIV test?
- If a confirmatory test is still needed, what is the advantage to sexually transmitted disease (STD) clinics of using rapid HIV testing?
- What is the advantage to clients of using rapid HIV Testing?
- Will people who have progressed to the late stages of AID continue to test positive on the rapid HIV test?
- Can rapid HIV tests be performed on infants?
- Can clinic staff batch rapid HIV tests?
- How long does the rapid HIV test take after the lab receives the specimen?
- What type of training will be available for HIV counselors at sites that use rapid HIV tests?
- Are educational materials (e.g., handouts, videos) available for the clinics that want to use rapid HIV tests?
- Would telephoning clients to provide the results of a positive confirmatory HIV test be acceptable?
- What does the counselor tell a client who has a reactive rapid HIV test?
- Do you start partner notification and referral services immediately upon receiving a reactive rapid HIV test result, or do you wait for the confirmatory test result?
- Should a physician prescribe antiretroviral treatment for a pregnant woman on the basis of rapid HIV test results (per the PHS Guidelines)?
- Are confirmatory tests necessary for a rapid HIV test result to be considered a diagnosis of HIV infection?
- Resources
- Understanding Viral Load
- What is viral load and how is it measured?
- When should viral load be measured?
- What prompts changes in viral load?
- What does an “undetectable” level mean?
- Is there still a need to have CD4+ levels monitored?
- Sex and HIV Prevention
- Prevention and Treatment of Sexually Transmitted Diseases as an HIV
- Prevention Strategy
- The Parallel Epidemics of HIV Infection and Other STDs
- Other STDs Facilitate HIV Transmission
- New Evidence of the Effectiveness of STD Treatment in HIV Prevention
- Condoms and Their Use in Preventing HIV Infection and Other STDs
- Condoms are effective in preventing HIV and other STDs
- Condoms must be used consistently and correctly to provide maximum protection
- Condoms users have product options
- Education about condom efficacy does not promote sexual activity
- Prevention is cost-effective
- Primary HIV Infection Associate with Oral Transmission
- What is the risk of HIV transmission from oral sex?
- What are the exact ways that HIV was transmitted in this study?
- How do you know if the study participants were telling the truth about their sexual history?
- Was this a surprise finding?
- What can be done to prevent HIV?
- Bibliography
- HIV Prevention Among Men who Have Sex with Men (MSM)
- Continuing Risk Among Young MSM
- Need to Combat Other STDs
- Prevention Services Must Reach Both Uninfected and Infected
- Women Who Have Sex With Women (WSW)
- What do surveillance tools tell us about transmission between women?
- What do investigations of female-to-female transmission show?
- What are the behaviors that place WSW at risk of HIV infection?
- What can WSW do to reduce their risk of contracting HIV?
- References
- IDUs and HIV
- Injection Drug Use and the Transmission of HIV and Other Blood-Borne Infections
- Critical Importance of Prevention and Treatment of Drug Dependence
- HIV Risks Associated With Drug Injection
- Recommendations to Drug Users Who Continue to Inject
- References
- Universal Precautions
- Universal Precautions for Prevention of Transmission of HIV, HBV, and Other
- Blood borne Pathogens in Healthcare Settings
- Introduction
- Body Fluids to Which Universal Precautions Apply
- Body Fluids to Which Universal Precautions Do Not Apply
- Precautions for Other Body Fluids in Special Settings
- Use of Protective Barriers
- Glove Use for Phlebotomy
- Selection of Gloves
- Waste Management
- References
- Occupational Exposures to Blood
- Introduction
- Are healthcare workers at risk of getting HIV on the job?
- How can occupational exposures be prevented?
- If An Exposure Occurs
- What should I do if I am exposed to the blood of a patient?
- Risk of Infection After Exposure
- What is the risk of infection after an occupational exposure?
- How many healthcare workers have been infected with bloodborne pathogens?
- Treatment for the Exposure
- Is vaccine or treatment available to prevent infections with bloodborne pathogens?
- What about exposures to blood from an individual whose infection status is unknown?
- What specific drugs are recommended for post exposure treatment?
- How soon after exposure to a bloodborne pathogen should treatment start?
- Has the FDA approved these drugs to prevent bloodborne pathogen infection following an occupational exposure?
- What is known about the safety and side effects of these drugs?
- Can pregnant healthcare workers take the drugs recommended for post exposure treatment?
- Follow-Up After An Exposure
- What follow-up should be done after an exposure
- What precautions should be taken during the follow-up period?
- Are patients in a dentist’s or doctor’s office at risk of getting HIV?
- Antiretroviral Therapy
- Attacking AIDS with a ‘Cocktail’ Therapy Drug Combo Sends Deaths Plummeting
- A “One-Two Punch”
- Regimen has drawbacks
- AIDS-related illnesses
- Pregnant women and children
- In the future
- Living with HIV/AIDS
- What is HIV and haw did I get it?
- What is the difference between HIV and AIDS?
- How can I stay healthy longer?
- What can I expect when I go to the doctor?
- What is the treatment for HIV or AIDS?
- What are some of the other diseases I could get?
- How do I protect other people from my HIV?
- Family Planning and Pregnancy
- Is there any special advice for women with HIV?
- What if I become pregnant?
- Where can I find help in fighting HIV?